FLT3 and acute myeloid leukemia: Inhibition of NLRP3 may exert a similar effect by mitigating inflammatory responses, which could render FLT3-ITD mutant AML cells more vulnerable to FLT3 inhibitors, thereby enhancing pro-apoptotic effects.